Unobangela womhlaza wesibindi ngo-2026: Unyango lwaseTshayina kunye neendleko-izibhedlele ezikufutshane nam

Iindaba

 Unobangela womhlaza wesibindi ngo-2026: Unyango lwaseTshayina kunye neendleko-izibhedlele ezikufutshane nam 

2026-04-09

Eyokuqala umhlaza wesibindi unobangela ngo-2026 uhlala usulelo olungapheliyo kunye ne-hepatitis B (HBV) kunye ne-hepatitis C (HCV) iintsholongwane, ezidityaniswa ngokunyuka kwamazinga e-metabolic dysfunction-associated steatotic isifo sesibindi (MASLD). E-China, unyango luguqukele kwiyeza elichanekileyo elidibanisa ukugonywa komzimba, ii-agent ekujoliswe kuzo, kunye nonyango oluphezulu lwendawo yokuhlala phantsi kwenkqubo ehlaziyiweyo ye-2026 ye-Barcelona Clinic ye-Liver Cancer (BCLC). Iindleko ziyohluka kakhulu ngokusekwe kwinqanaba lesigulo nakwinqanaba lesibhedlele, kunye ne-inshurensi yoluntu ebandakanya inxalenye enkulu yokhathalelo oluqhelekileyo.

Ukuqonda iMbangela yoMhlaza weSibindi oPhambili ngo-2026

Ukuchonga ingcambu umhlaza wesibindi unobangela ibalulekile kuthintelo kunye nokubhaqwa kwangoko. Ngelixa i-viral hepatitis ihlala ingumqhubi ophambili kwihlabathi, imeko ye-epidemiological e-China iyatshintsha ngenxa yeenkqubo zokugonywa eziyimpumelelo kunye nokutshintsha kwendlela yokuphila.

Usulelo olungapheliyo lweHepatitis B lubangela uninzi lweemeko ze-hepatocellular carcinoma (HCC) eTshayina. Ngaphandle kogonyo oluxhaphakileyo, inani elikhulu labantu abadala abadala bathwala intsholongwane, ekhokelela kwi-cirrhosis kunye ne-malignancy ekugqibeleni. Ukuhlanganiswa kwee-nucleos (t) ze-ide analogues ezinamandla ziye zancitshiswa kodwa azizange ziphelise lo mngcipheko.

IHepatitis C ihleli inegalelo elibalulekileyo, nangona ii-antivirals ezisebenza ngokuthe ngqo (DAAs) ziye zawaphucula kakhulu amazinga okunyanga. Nangona kunjalo, izigulana ezine-fibrosis ephezulu ngexesha lokunyangwa zisenomngcipheko ophakamileyo wokuba nomhlaza wesibindi, nto leyo efuna ukubekw' esweni ubomi bonke.

A ivela ngokukhawuleza umhlaza wesibindi unobangela kukungasebenzi kakuhle kwemetabolism. Ngamazinga okutyeba aphindaphindeka kathathu e-China ukusukela ngo-2004, isifo sesibindi esinamafutha angasinxilisi (ngoku esibizwa ngokuba yi-MASLD) siya kuba yi-etiology ehamba phambili. Olu tshintsho lubonisa iindlela zehlabathi apho i-metabolic syndrome iqhuba i-carcinogenesis ezimeleyo kwintsholongwane yentsholongwane.

  • Imiba yentsholongwane: Izifo ezingapheliyo ze-HBV kunye ne-HCV zibangela ukudumba okuqhubekayo kunye nomonakalo we-DNA.
  • Imiba yeMetabolic: Ukutyeba ngokugqithiseleyo, uhlobo lwe-2 yeswekile, kunye nesifo sesibindi esinamafutha senza indawo ye-pro-inflammatory.
  • Ukutyhileka okunetyhefu: Ukuvezwa kwe-Aflatoxin, ehlala idityaniswa nokutya okungagcinwanga ngendlela efanelekileyo, idibana ne-HBV ukonyusa umngcipheko.
  • Ukusetyenziswa kotywala: Ukusela kakhulu kukhawulezisa i-fibrosis yesibindi kwaye kwandisa ukuchaphazeleka komhlaza.

Idatha yamva nje evela kwi-CDC yaseChina igxininisa ukuba ulawulo lobunzima ngoku lusisiseko sezicwangciso zokuthintela umhlaza. Utshintsho olusuka kuvavanyo olusebenzayo ukuya kungenelelo lwendlela yokuphila engxamisekileyo lubalulekile ukunqanda ukunyuka kwamaza omhlaza wesibindi onento yokwenza nemetabolism.

Uhlaziyo luka-2026 e-China IiProtokholi zoNyango loMhlaza wesibindi

Iiparadigms zonyango e-China ziye zaphuculwa kakhulu ngo-2026, zikhokelwa yinkqubo yamva nje ye-Barcelona Clinic Liver Cancer (BCLC). Olu hlaziyo lugxininisa indlela yesigulane-centric, ukulinganisa ubungqina bekliniki kunye nemilinganiselo yesigulane kunye neemeko.

Isakhelo esitsha sesiGqibo se-CUSE

Uhlaziyo lwe-2026 BCLC luzisa isakhelo se-CUSE, esimele ukuNxina, ukungaqiniseki, ukuzithoba, kunye ne-Emotion. Lo mzekelo ukhokela amaqela amacandelo amaninzi ukwenza izigqibo zenzululwazi kunye nezomntu.

Endaweni yokulandela ngokungqongqo itshati, oogqirha ngoku bavavanya ngokucwangcisekileyo imilinganiselo emine. Bavavanya ukuntsonkotha kwesi sifo, ukungaqiniseki kwesi sifo, izinto ezikhethwa ngumguli, kunye neemeko ezingokweemvakalelo eziphembelela ukhetho lonyango.

Olu tshintsho luqinisekisa ukuba izicwangciso zonyango azifanelekanga nje ngokwebhayoloji kodwa zihambelana neenjongo zobomi besigulane kunye nokulungela kwengqondo. Imele inyathelo eliya kukhathalelo lwenyani lwe-oncology kumaziko ezonyango aseTshayina.

Ukuqhubela phambili kuNyango lwakwaQala (BCLC 0/A)

Kumhlaza wesibindi kwangethuba kwaye kwasekuqaleni, uluhlu lweendlela zokunyanga luye lwanda. Ngokwesiko kunqunyelwe kuqhaqho loqhaqho kunye nokukhutshwa, izikhokelo ze-2026 ngoku zibandakanya ngokusesikweni iStereotactic Body Radiation Therapy (SBRT) kunye neTransarterial Radioembolization (TARE).

Ezi zongezo zibonelela ngeendlela ezizezinye ezibalulekileyo kwizigulana ezingabagqalwa botyando ngenxa yeengxaki ze-anatomical okanye izifo eziye zadibana nazo. I-SBRT inikezela ngemitha echanekileyo ephezulu echaphazela kancinci iithishu zesibindi ezisempilweni.

I-TARE, okanye i-radioembolization, ihambisa imitha ngokuthe ngqo kwithumba nge-hepatic artery. Lo buchule bubini bokwenza i-embolization kunye nemitha yenza ukuba ibe sisixhobo esinamandla sokulawula isifo sendawo ngelixa sigcina ukusebenza kwesibindi.

Ukulawula izifo zeNqanaba eliPhakathi (BCLC B)

Ulawulo lomhlaza wesibindi wenqanaba eliphakathi lube ngumxholo wengxoxo enzulu. Ukuvumelana kwe-2026 kucacisa ukuba ubungqina obukhoyo abuxhasi ukudibanisa okuqhelekileyo kwonyango lokungenelela (njenge-TACE) kunye ne-systemic therapy kuzo zonke izigulane ezikweli qela.

Ngelixa olunye ulingo lucebise ngeenzuzo, idatha iyonke ibonisa ukuba indibaniselwano engakhethi buso inokonyusa ubutyhefu ngaphandle kweenzuzo ezilinganayo zokusinda. Izigqibo zonyango apha zifuna i-stratification ngononophelo ngokusekelwe kumthwalo wethumba kunye nokugcinwa kwesibindi.

Oogqirha bayakhuthazwa ukuba basebenzise ingcamango "yokufuduka kwesigaba sonyango". Ukuba isigulana siphendula kakuhle kakhulu kunyango lwengingqi, zisenokuthotyelwa kwinjongo yonyango. Ngakolunye uhlangothi, ukuqhubela phambili kunokufuna ukutshintshela kwangaphambili kwiinketho zesistim.

Unyango lweNkqubo yeSigaba esiPhezulu (BCLC C)

Kwinqanaba eliphezulu, i-immunotherapy edibeneyo kunye ne-anti-angiogenic agents iye yaqinisa isikhundla sayo njengomgangatho wokuqala wokunyamekela. Le rejimeni ibonise ukusinda jikelele okuphezulu xa kuthelekiswa ne-kinase inhibitors yangaphambili yodwa.

I-synergy phakathi kwe-immune checkpoint inhibitors kunye neziyobisi eziqhelanisa imithambo yegazi ye-tumor kudala impendulo eyomeleleyo yokuchasana nethumba. Ulingo lwezonyango lwaseTshayina lube negalelo elikhulu ekuqinisekiseni ezi ndibaniselwano kubantu abahlukeneyo.

Uphando oluqhubekayo luyaqhubeka nokuphonononga unyango oluphindwe kathathu kunye neethagethi zenoveli, kodwa umqolo okhoyo uhlala uyindlela yokudibanisa i-immuno-combination. Le ndlela iguqule umhlaza wesibindi ophezulu ukusuka kwisifo esibulalayo ngokukhawuleza ukuya kwimeko elawulekayo engapheliyo kwabaninzi.

Ukufumana izibhedlele ezikufutshane nam: Amaziko aphezulu eTshayina

Ukufumana indawo efanelekileyo yonyango linyathelo elibalulekileyo emva kokuqonda umhlaza wesibindi unobangela kunye neendlela zonyango. I-China inamaziko amaninzi akumgangatho wehlabathi asebenza nge-hepatobiliary oncology, ebonelela ngokhathalelo lwezifundo ezininzi.

Izibhedlele eziphambili zihlala ziseka amaqela athile entsebenziswano kumhlaza wesibindi, ukudibanisa utyando, i-radiology yokungenelela, i-oncology yonyango, kunye ne-pathology. Le modeli yentsebenziswano iqinisekisa ukuba isigulana ngasinye sifumana isicwangciso sonyango esiqhelekileyo kodwa esahlukileyo.

KwiYunivesithi yaseFudan kwisibhedlele saseZhongshan

Ifumaneka eShanghai, iYunivesithi yaseFudan isibhedlele saseZhongshan singuvulindlela kuphando lomhlaza wesibindi kunye nonyango. ISebe loTyando lweSibindi kunye neZiko loMhlaza weSibindi apha zivunywa kwihlabathi jikelele.

UProf. Gao Qiang kunye neqela lakhe baye bancedisa ekuqulunqeni ukuhlaziywa kwe-BCLC ye-2026. Isibhedlele sigqwesa kwi-resections eyinkimbinkimbi, ukutshintshwa kwesibindi, kunye neendlela ezintsha zonyango zokungenelela.

Bathatha inxaxheba ngokukhutheleyo kulingo lwezonyango lwasekhaya nakwamanye amazwe, ukubonelela izigulana ukufikelela kunyango oluphambili phambi kokuba zifumaneke ngokubanzi. Inkqubo yabo yeqela lezinto ezininzi luphawu lwesizwe.

Amanye amaZiko oNyango aPhambili

Ngaphaya kweShanghai, ezinye izixeko ezikhulu zibamba amaziko aphezulu. IBeijing, iGuangzhou, kunye neChengdu zinezibhedlele ezineeyunithi ezizinikeleyo zomhlaza wesibindi ezikwaziyo ukuphatha iimeko ezinomthamo omkhulu.

La maziko abonisa amagumbi okucinga akumgangatho ophezulu woxilongo oluchanekileyo kunye namagumbi okusebenza aphucukileyo kwiinkqubo ezingephi. Bakwanikezela ngeenkonzo zokhathalelo olubanzi lwenkxaso.

Xa kukhangelwa “izibhedlele ezikufutshane nam,” izigulana kufuneka zijonge amaziko avunyiweyo oqhaqho-fakelo lwesibindi kunye nalawo anenxaxheba ebonakalayo kwiirejistri zesizwe zomhlaza. Oku kuqinisekisa ukuthotyelwa kwemigangatho yamva nje yomgangatho kunye nezenzo eziqhutywa yidatha.

  • Amaqela aManinzi: Jonga izibhedlele ezinamabele adibeneyo, i-gastric, i-lymphoma, kunye namaqela omhlaza wesibindi.
  • Uvavanyo lweklinikhi: Amaziko aqhuba ulingo oluqhubekayo akholisa ukunika ufikelelo kumachiza esizukulwana esilandelayo.
  • Amaxabiso oTyando oluLondolozayo: Amazinga aphezulu otyando olugcina amalungu abonisa ubuchule botyando obuphezulu.

Uhlalutyo lweendleko zoNyango loMhlaza wesibindi ngo-2026

Ukuqonda iimpembelelo zemali zonyango lomhlaza wesibindi kubalulekile kwizigulane kunye neentsapho. Iindleko e-China ziyahluka ngokubanzi ngokuxhomekeke kwinqanaba lesi sifo, indlela yonyango ekhethiweyo, kunye nenqanaba elithile lesibhedlele.

Abaqhubi beendleko ngokweModyuli yoNyango

Uqhaqho loqhaqho luhlala lulolona nyango luneendleko ezisebenzayo ukuba isigulane sifanelekile. Nangona kunjalo, iindleko zangaphambili zibandakanya uvavanyo lwangaphambi kotyando, inkqubo ngokwayo, ukuhlala kwe-ICU, kunye nokhathalelo lwasemva kotyando.

Unyango lwengingqi, olufana ne-radiofrequency ablation (RFA), luba neendleko eziphantsi kunotyando olukhulu. Zibandakanya ukuhlala esibhedlele ixesha elifutshane kunye nokusetyenziswa okuncinci kwezibonelelo, okwenza ukuba zifikeleleke kwizilonda zakwangoko.

Iinkqubo zongenelelo ngeradiology ezifana ne-TACE zinokuqokelela iindleko ngokuhamba kwexesha, njengoko zihlala zifuna iiseshini eziphindaphindiweyo ukulawula ukukhula kwethumba. Ixabiso ngeseshoni nganye liyahluka ngokusekelwe kwi-embolic agents kunye nesikhokelo sokucinga esisetyenzisiweyo.

Unyango olucwangcisiweyo, ngakumbi indibaniselwano ye-immunotherapy, imele ezona ndleko ziphezulu ziqhubekayo. Ngelixa amaxabiso ehlile ngenxa yemigaqo-nkqubo yokuthenga esekelwe kumthamo wesizwe, ulawulo lwexesha elide lusengumthwalo wemali.

Ukhuseleko lwe-inshurensi kunye nembuyekezo

Inkqubo ye-inshurensi yonyango esisiseko yaseTshayina iquka inxalenye ebalulekileyo yonyango oluqhelekileyo lomhlaza wesibindi. Amachiza abalulekileyo, kubandakanywa ezininzi zonyango ezijoliswe kuzo kunye ne-immunotherapies, zifakwe kuluhlu lwembuyekezo lukazwelonke.

Nangona kunjalo, iiarhente ezitsha okanye ezo zisetyenzisiweyo ngaphandle kweleyibhile zinokufuna intlawulo ephuma epokothweni. I-inshurensi eyongezelelweyo yorhwebo iya idume ngokuvala lo msantsa kunye nokuhlawula iindleko ezingabuyiswa.

Izigulana zicetyiswa ukuba ziqhagamshelane noonontlalontle basesibhedlele okanye abanxibelelanisi beinshorensi ukuze baqonde imida yabo ethile yokhuseleko. Iinkqubo zoncedo lwemali ezivela kwiinkampani ezixuba amayeza zinokufumaneka kubantu abafanelekileyo.

Uhlobo loNyango Uluhlu lweendleko eziqikelelweyo (CNY) Ubume be-Inshorensi yokuBonelela
Uqhaqho loKutyandwa 50,000 - 150,000 Phezulu (Inxalenye enkulu igutyungelwe)
Ukukhutshwa kwendawo (RFA/MWA) 20,000 - 60,000 Phezulu
TACE (Ngeseshini nganye) 15,000 - 40,000 Phakathi ukuya Phezulu
Immunotherapy + ekujoliswe kuyo 10,000 - 30,000 / ngenyanga Iyaguquguquka (Iininzi ngoku ibuyiselwe)
UTshintsho lwesibindi 400,000 - 800,000+ Ilinganiselwe (Iyahluka ngokwengingqi)

Ulawulo lwasemva koCando kunye noThintelo lokuPhinda

Unyango lokuqala oluyimpumelelo lidabi lokuqala kuphela. Ukuthintela ukuphindaphinda kubaluleke kakhulu, njengoko amazinga aphezulu okuphinda abuyele kumhlaza wesibindi. I-2026 Expert Consensus kwi-Adjuvant Therapy inikezela ngezikhokelo ezicacileyo zokunyamekela emva kokusebenza.

Umngcipheko wokuphindaphinda

Ukuphindaphinda kuhlelwe kwangaphambili (kwiminyaka emi-2) kunye nasemva kwexesha (emva kweminyaka emi-2) iziganeko, ngasinye sinezizathu ezahlukileyo. Ukuphindaphinda kwangethuba kudla ngokubakho ngenxa yeemetastase ezincinci ezikhoyo phambi kotyando okanye ukusasazwa kwe-intraoperative.

Izinto ezinobungozi obuphezulu bokuphindaphinda kwangethuba ziquka amathumba amaninzi, ubukhulu be-tumor enkulu (> 5cm), ukuhlukana okungahambi kakuhle, ukuhlaselwa kwe-vascular, kunye nemida emihle. Ukuchonga ezi zinto kunceda ukulungelelanisa amaqhinga adjuvant.

Ukuphindaphinda kade kudla ngokuba lithumba elitsha lokuqala elivela kwisibindi esigulayo. Izinto ezifana ne-viral hepatitis, i-cirrhosis enzima, kunye neminyaka zidlala indima enkulu apha. Ukulawula isifo sesibindi semvelaphi ngundoqo ekuthinteleni ezi ziganeko zamva.

Izicwangciso ze-Adjuvant Therapy

Imvumelwano ikhuthaza ukuba "unyango olusisiseko + ungenelelo lomntu ngamnye". Zonke izigulana kufuneka zifumane ulawulo olululo lwesifo sabo sesibindi esisisiseko phambi kokuba ziqwalasele unyango olongezelelweyo lomhlaza.

Kumhlaza onxulumene ne-HBV, unyango lwe-antiviral yobomi bonke olune-high-barrier nucleos(t)ide analogues lunyanzelekile. Amachiza afana ne-entecavir okanye i-tenofovir acinezela kakhulu ukuphindaphinda kwentsholongwane kwaye anciphise umngcipheko wokuphindaphinda.

Kwizigulane ezinobungozi obuphezulu, unyango lwe-systemic adjuvant okanye ukungenelela kwendawo kunokucetyiswa. Ukhetho luxhomekeke kwiprofayili ethile yomngcipheko kunye nokunyamezela kwesigulane. Ulingo lwezonyango luphonononga indibaniselwano eyahlukeneyo ukufumana ezona rejimeni zisebenzayo.

  • Unyango lwe-Antiviral: Kubalulekile kwizigulane ze-HBV / HCV ukuzinzisa ukusebenza kwesibindi.
  • Ukubek' esweni: Ukucinga rhoqo kunye nokubeka iliso kwi-AFP rhoqo kwiinyanga ezi-3-6.
  • Ukuguqulwa kwendlela yokuphila: Ukulawulwa kobunzima kunye nokuyeka utywala ukunciphisa uxinzelelo lwe-metabolic.

Indima yokuPhila kunye noLawulo lobunzima

Ukujongana neengcambu umhlaza wesibindi unobangela kudla ngokufuna iinguqu ezinzulu kwindlela yokuphila. Ngokunyuka kwezifo zesibindi ezinxulumene ne-metabolic, ulawulo lobunzima luye lwaba yinto ebalulekileyo yokukhusela kunye nokunyamekela emva konyango.

Ukutyeba ngoyena mqhubi uphambili wokudumba okungapheliyo kunye nokumelana ne-insulin, kudala umhlaba ochumileyo wophuhliso lomhlaza. Uphononongo lubonisa ulungelelwaniso oluqinileyo phakathi kwezalathi ze-adiposity kunye nomngcipheko womhlaza ngokulandela ixesha elide.

E-China, ukuxhaphaka kokutyeba kunyuke kakhulu, kubangela umngeni omkhulu kwimpilo yoluntu. Uthintelo olusebenzayo lomhlaza ngoku lufuna utshintsho olubhekiselele kwiindlela ezisebenzayo, zobomi ezigxile kungenelelo lokuziphatha.

Izigulane zikhuthazwa ukuba zamkele ukutya okunesondlo nokuzilolonga rhoqo. Nokuba ukuncipha kobunzima obuncinci kunokuphucula i-histology yesibindi kunye nokunciphisa umngcipheko wokuqhubekela phambili kwi-cirrhosis kunye nomhlaza.

Ukudibanisa iMpilo yoLuntu kunye noNyango lwezonyango

Kukho ukuqondwa okukhulayo kwesidingo sokuhlanganiswa okungcono phakathi kweenkonzo zeklinikhi kunye namanyathelo ezempilo yoluntu. Intsebenziswano yamacandelo amaninzi ibalulekile ukudala izikhokelo zokuthintela umhlaza ezizinzileyo.

Izibhedlele ziya ngokuya zisebenzisana namaziko ezempilo oluntu ukukhuthaza iinkqubo zokulawula ubunzima. La manyathelo ajolise ekumiseleni indlela yokuziphatha esempilweni kuwo onke amanqanaba othintelo.

Ukomeleza unxibelelwano olusemngciphekweni kunceda izigulane ziqonde ikhonkco phakathi kwendlela yokuphila kunye nomngcipheko womhlaza. Izigulana ezixhotyisiweyo kunokwenzeka ukuba zibambelele kumanyathelo othintelo kunye neeprothokholi zokucupha.

Ukuhamba ngeNkqubo yoLondolozo lwezeMpilo: Isikhokelo sesigulane

Ukujonga imeko yezempilo enzima kunokuba nzima. Indlela ecwangcisiweyo iqinisekisa ukuba izigulane zifumana ukhathalelo olusexesheni nolufanelekileyo. Nali inyathelo ngenyathelo isikhokelo kwabo bafuna uncedo.

Amanyathelo OmawaThatha Emva Kokuxilongwa

Okokuqala, qinisekisa ukuxilongwa kunye nenqanaba ngokusebenzisa umfanekiso obanzi kunye ne-biopsy ukuba kuyimfuneko. Iqonga elichanekileyo lisisiseko sokukhetha indlela yonyango echanekileyo.

Okwesibini, funa ukubonisana ngezinto ezininzi. Musa ukuxhomekeka kuluvo lwengcali enye. Iqela elibandakanya oogqirha botyando, i-oncologists, kunye neengcali ze-radiologists zibonelela ngombono opheleleyo wezinto onokukhetha kuzo.

Okwesithathu, xoxa ngesikhokelo se-CUSE kunye noogqirha bakho. Yabelana ngemilinganiselo yakho yobuqu, uloyiko, kunye neenjongo. Le ncoko yababini iqinisekisa ukuba isicwangciso sonyango sihlonipha ubuntu bakho.

Okwesine, qinisekisa i-inshurensi kwaye ujonge iindlela zoncedo lwemali. Ukuqonda iindleko kwangaphambili kuthintela ukuphazamiseka kunyango ngenxa yeengxaki zemali.

  • Inyathelo 1: Fumana inqanaba elichanekileyo kunye neprofayili yemolekyuli.
  • Inyathelo lesi-2: Qhagamshelana nebhodi yethumba enezinto ezininzi.
  • Inyathelo lesi-3: Vavanya izinto ozikhethayo kunye nokulungela ngokweemvakalelo.
  • Inyathelo lesi-4: Ukhuseleko lwesicwangciso semali kunye nokuvunywa kwe-inshorensi.

Izikhokelo zexesha elizayo kukhathalelo lomhlaza wesibindi

Ikamva lonyango lomhlaza wesibindi lijongeka lithembisa ngenkqubela phambili eqhubekayo kwitekhnoloji kunye nonyango. Uphando lujolise ekoyiseni ukuchasana nonyango lwangoku kunye nokuchonga iithagethi ezintsha.

Iyeza lobuqu liya lisiba yinyani, ngonyango olulungelelaniswe nokwakheka kwemfuza yamathumba. I-biopsies yolwelo inokuvumela kwakamsinya ukujongwa kwexesha lokwenyani lokutshintsha kwesifo ngaphandle kweenkqubo ezihlaselayo.

Ukudityaniswa kobukrelekrele bokwenziwa kwimifanekiso kunye ne-pathology kuphucula ukuchaneka kokuxilonga. Ii-algorithms ze-AI zinokubona iipateni ezifihlakeleyo ezingabonakaliyo kwiliso lomntu, zinceda ekubhaqweni kwangaphambili kunye nokuxela kwangaphambili.

Ngaphaya koko, ukwanda kothungelwano lolingo lwezonyango e-China kuqinisekisa ukuba izigulana ziyafikelela kwizinto ezintsha ezintsha. Intsebenziswano phakathi kwezifundiswa, ishishini, kunye norhulumente ikhawulezisa ukuguqulelwa kophando ekusebenzeni.

Ukuqukumbela

Ukuqonda i umhlaza wesibindi unobangela linyathelo lokuqala eliya kuthintelo nolawulo olusebenzayo. Ngo-2026, i-China imi phambili kukhathalelo lomhlaza wesibindi, ixhasa iinkqubo zeqonga ezihlaziyiweyo, unyango oluphucukileyo, kunye nentanda-bulumko yesigulana.

Ukususela ekuqalisweni kwenkqubo-sikhokelo yesigqibo se-CUSE ukuya ekwandisweni kweenketho zonyango ezifana ne-SBRT kunye ne-TARE, imbonakalo-mhlaba iguquka ngokukhawuleza. Ngelixa imiceli mngeni ihleli, ngakumbi malunga neemeko zomngcipheko kunye neendleko, umkhondo ulungile.

Izigulane zikhuthazwa ukuba zifune ukhathalelo kumaziko akhethekileyo, zibambelele kwiingcebiso ze-antiviral kunye nendlela yokuphila, kwaye zibandakanye ngokukhutheleyo kwizigqibo zabo zonyango. Ngenkxaso efanelekileyo kunye nezibonelelo, iziphumo zezigulane zomhlaza wesibindi ziyaqhubeka ziphucula.

Ngokudibanisa ubuchule bezonyango kunye nokuxhotyiswa komntu, sinokujamelana nemingeni yomhlaza wesibindi ngokufanelekileyo. Uhambo olusuka kuxilongo ukuya ekuchacheni luntsonkothile, kodwa indlela icace ngakumbi kwaye inethemba ngakumbi kunangaphambili.

Ekhaya
Amatyala aqhelekileyo
Malunga Nathi
Qhagamshelana nathi

Nceda usishiyele umyalezo